From January 1, 2024 to March 31, 2024, the company has repurchased 12,971,308 shares, representing 2.43% for CNY 147.82 million. With this, the company has completed the repurchase of 20,172,808 shares, representing 3.79% for CNY 243.66 million under the buyback announced on November 20, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.45 CNY | -0.53% | +0.85% | -29.64% |
Apr. 24 | ChenGuang Biotech Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 24 | ChenGuang Biotech Group Co., Ltd.announces an Increase in Equity Buyback. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.64% | 696M | |
-5.45% | 264B | |
-0.68% | 96.77B | |
+4.41% | 46.94B | |
-0.03% | 40.26B | |
+8.17% | 39.78B | |
+4.01% | 39.6B | |
-18.78% | 29.43B | |
-5.77% | 28.95B | |
+11.53% | 24.86B |
- Stock Market
- Equities
- 300138 Stock
- News ChenGuang Biotech Group Co., Ltd.
- Tranche Update on ChenGuang Biotech Group Co., Ltd.'s Equity Buyback Plan announced on November 20, 2023.